Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

PCSK9 inhibitors and managing cost in the managed care setting.

Stadler SL, Cook TJ.

Am J Manag Care. 2017 Jun;23(9 Suppl):S149-S155. Review.

2.

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease.

Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Montine TJ, Banks WA, Zhang J.

Alzheimers Dement. 2016 Nov;12(11):1125-1131. doi: 10.1016/j.jalz.2016.04.003. Epub 2016 May 24.

3.

Mortalin is Expressed by Astrocytes and Decreased in the Midbrain of Parkinson's Disease Patients.

Cook TJ, Hoekstra JG, Eaton DL, Zhang J.

Brain Pathol. 2016 Jan;26(1):75-81. doi: 10.1111/bpa.12274. Epub 2015 Jul 27.

4.

Astrocytic dynamin-like protein 1 regulates neuronal protection against excitotoxicity in Parkinson disease.

Hoekstra JG, Cook TJ, Stewart T, Mattison H, Dreisbach MT, Hoffer ZS, Zhang J.

Am J Pathol. 2015 Feb;185(2):536-49. doi: 10.1016/j.ajpath.2014.10.022. Epub 2014 Dec 4.

5.

Blood α-synuclein in agricultural pesticide handlers in central Washington State.

Searles Nielsen S, Checkoway H, Zhang J, Hofmann JN, Keifer MC, Paulsen M, Farin FM, Cook TJ, Simpson CD.

Environ Res. 2015 Jan;136:75-81. doi: 10.1016/j.envres.2014.10.014. Epub 2014 Nov 20.

6.

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, Hipp MJ, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Banks WA, Zhang J.

Acta Neuropathol. 2014 Nov;128(5):639-650. doi: 10.1007/s00401-014-1314-y. Epub 2014 Jul 6.

8.

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease.

Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J.

Sci Rep. 2012;2:954. doi: 10.1038/srep00954. Epub 2012 Dec 11.

9.

Biomarkers of Parkinson's disease: current status and future perspectives.

Wang J, Hoekstra JG, Zuo C, Cook TJ, Zhang J.

Drug Discov Today. 2013 Feb;18(3-4):155-62. doi: 10.1016/j.drudis.2012.09.001. Epub 2012 Sep 11. Review.

10.

A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.

Cook TJ, Qiu CC, Dickinson JE.

Aust N Z J Obstet Gynaecol. 2012 Aug;52(4):321-6. doi: 10.1111/j.1479-828X.2012.01438.x. Epub 2012 Apr 17. Review.

PMID:
22510050
11.

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I.

Lancet. 2010 Feb 27;375(9716):735-42. doi: 10.1016/S0140-6736(09)61965-6. Epub 2010 Feb 16.

PMID:
20167359
12.

Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta.

Xu Y, Agrawal S, Cook TJ, Knipp GT.

Placenta. 2008 Nov;29(11):962-9. doi: 10.1016/j.placenta.2008.08.011. Epub 2008 Sep 30.

13.

Improved intestinal membrane permeability of hexose-quinoline derivatives via the hexose transporter, SGLT1.

Otake K, Suzuki H, Higashi R, Yabuuchi H, Haga M, Maeda T, Cook TJ, Tamai I.

J Pharm Sci. 2008 May;97(5):1821-30.

PMID:
17828732
15.
16.

Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial.

Lanas A, Baron JA, Sandler RS, Horgan K, Bolognese J, Oxenius B, Quan H, Watson D, Cook TJ, Schoen R, Burke C, Loftus S, Niv Y, Ridell R, Morton D, Bresalier R.

Gastroenterology. 2007 Feb;132(2):490-7. Epub 2006 Nov 10.

PMID:
17258718
17.

Characterization and in vitro degradation of salicylate-derived poly(anhydride-ester microspheres).

Yeagy BA, Prudencio A, Schmeltzer RC, Uhrich KE, Cook TJ.

J Microencapsul. 2006 Sep;23(6):643-53.

PMID:
17118880
18.

Impact of neurohormonal blockade on association between body mass index and mortality.

Kennedy LM, Anker SD, Kjekshus J, Cook TJ, Willenheimer R.

Int J Cardiol. 2007 Jun 25;119(1):33-40. Epub 2006 Oct 17.

PMID:
17052777
19.

Di-(2-ethylhexyl)-phthalate affects lipid profiling in fetal rat brain upon maternal exposure.

Xu Y, Agrawal S, Cook TJ, Knipp GT.

Arch Toxicol. 2007 Jan;81(1):57-62. Epub 2006 Sep 2.

PMID:
16951938
20.

Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease.

Kennedy LM, Dickstein K, Anker SD, James M, Cook TJ, Kristianson K, Willenheimer R.

Eur Heart J. 2006 Dec;27(23):2755-62. Epub 2006 Aug 4.

PMID:
16891382
21.

Simultaneous determination of sulforaphane and its major metabolites from biological matrices with liquid chromatography-tandem mass spectroscopy.

Agrawal S, Winnik B, Buckley B, Mi L, Chung FL, Cook TJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Aug 18;840(2):99-107.

PMID:
16766235
22.

Methods for investigating placental fatty acid transport.

Xu Y, Cook TJ, Knipp GT.

Methods Mol Med. 2006;122:265-84.

PMID:
16511987
23.

Effects of di-(2-ethylhexyl)-phthalate and its metabolites on the lipid profiling in rat HRP-1 trophoblast cells.

Xu Y, Knipp GT, Cook TJ.

Arch Toxicol. 2006 May;80(5):293-8. Epub 2005 Nov 23.

PMID:
16328440
24.
25.

Expression of CYP4A isoforms in developing rat placental tissue and rat trophoblastic cell models.

Xu Y, Knipp GT, Cook TJ.

Placenta. 2005 Feb-Mar;26(2-3):218-25.

PMID:
15708123
26.
27.

Expression of PPAR, RXR isoforms and fatty acid transporting proteins in the rat and human gastrointestinal tracts.

Wang Q, Herrera-Ruiz D, Mathis AS, Cook TJ, Bhardwaj RK, Knipp GT.

J Pharm Sci. 2005 Feb;94(2):363-72.

PMID:
15614817
28.

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.

Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyörälä K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ; Scandinavian Simavastatin Survival Study Group.

Atheroscler Suppl. 2004 Oct;5(3):99-106. No abstract available.

PMID:
15531282
29.

Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets.

Cook TJ, Edwards S, Gyemah C, Shah M, Shah I, Fox T.

J Am Pharm Assoc (2003). 2004 Sep-Oct;44(5):583-6.

PMID:
15496044
31.

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

Strandberg TE, Pyörälä K, Cook TJ, Wilhelmsen L, Faergeman O, Thorgeirsson G, Pedersen TR, Kjekshus J; 4S Group.

Lancet. 2004 Aug 28-Sep 3;364(9436):771-7.

PMID:
15337403
33.

Effect of chlorpyrifos on efflux transporter gene expression and function in Caco-2 cells.

Agarwala S, Chen W, Cook TJ.

Toxicol In Vitro. 2004 Aug;18(4):403-9.

PMID:
15130596
34.
36.
37.

Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.

Roehrborn CG, McConnell JD, Saltzman B, Bergner D, Gray T, Narayan P, Cook TJ, Johnson-Levonas AO, Quezada WA, Waldstreicher J; PLESS Study Group. Proscar Long-term Efficacy and Safety Study.

Eur Urol. 2002 Jul;42(1):1-6.

PMID:
12121721
38.

Stability of calcitonin salmon in nasal spray at elevated temperatures.

Cook TJ, Shenoy SS.

Am J Health Syst Pharm. 2002 Apr 15;59(8):713-5.

PMID:
11977855
39.

Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.

Ridker PM, Shih J, Cook TJ, Clearfield M, Downs JR, Pradhan AD, Weis SE, Gotto AM Jr; Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Investigators.

Circulation. 2002 Apr 16;105(15):1776-9.

40.

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J.

Circulation. 2001 Dec 18;104(25):3046-51.

41.
42.
44.

Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia.

Kaplan SA, Holtgrewe HL, Bruskewitz R, Saltzman B, Mobley D, Narayan P, Lund RH, Weiner S, Wells G, Cook TJ, Meehan A, Waldstreicher J; Proscar Long-Term Efficacy and Safety Study Group.

Urology. 2001 Jun;57(6):1073-7.

PMID:
11377309
45.

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.

Pedersen TR, Wilhelmsen L, Faergeman O, Strandberg TE, Thorgeirsson G, Troedsson L, Kristianson J, Berg K, Cook TJ, Haghfelt T, Kjekshus J, Miettinen T, Olsson AG, Pyörälä K, Wedel H.

Am J Cardiol. 2000 Aug 1;86(3):257-62.

PMID:
10922429
46.

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, Pyörälä K.

Arch Intern Med. 1999 Dec 13-27;159(22):2661-7.

PMID:
10597756
47.

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.

Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH, Castellanos R, Coffield S, Saltzman B, Resnick M, Cook TJ, Waldstreicher J.

Urology. 1999 Mar;53(3):473-80.

PMID:
10096369
48.

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.

Andriole GL, Guess HA, Epstein JI, Wise H, Kadmon D, Crawford ED, Hudson P, Jackson CL, Romas NA, Patterson L, Cook TJ, Waldstreicher J.

Urology. 1998 Aug;52(2):195-201; discussion 201-2.

PMID:
9697781
49.

When allergies and asthma complicate pregnancy.

Lipkowitz MA, Schatz M, Cook TJ, Ford L, Frankel SJ, Gluck J, Leibner D, Leija JG, Luskin A, Ortega-Carr D, Spector SL.

Ann Allergy Asthma Immunol. 1998 Jul;81(1):30-4. No abstract available.

PMID:
9690570
50.

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyörälä K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ.

Circulation. 1998 Apr 21;97(15):1453-60.

Supplemental Content

Support Center